Detection of hypoxia in human squamous cell carcinoma by EF5 binding.
暂无分享,去创建一个
S M Evans | E M Lord | R. Weber | A. Chalian | S. Hahn | C. Koch | W. Mckenna | W. T. Jenkins | S. Evans | I. Benjamin | C. Stevens | N. Mirza | G. Weinstein | E. Lord | W G McKenna | M. Morgan | C J Koch | G. Weinstein | W T Jenkins | S Hahn | D R Pook | A A Chalian | P Zhang | C Stevens | R Weber | G Weinstein | I Benjamin | N Mirza | M Morgan | S Rubin | S. Hahn | R. Weber | N. Mirza | Paul Zhang | I. Benjamin | M. Morgan | S. Rubin | P. Zhang | D. R. Pook | P. Zhang | P. Zhang | Deirdre R. Pook
[1] S M Evans,et al. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode. , 2000, International journal of radiation oncology, biology, physics.
[2] M C Weissler,et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. , 1998, Cancer research.
[3] A. Fyles,et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] B. Fenton,et al. Interleukin 2 expression by tumor cells alters both the immune response and the tumor microenvironment. , 1998, Cancer research.
[5] S. Lahiri,et al. Tissue oxygen sensing and the carotid body. , 1998, Advances in experimental medicine and biology.
[6] B. Siim,et al. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia. , 1997, Cancer research.
[7] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[8] B. Wouters,et al. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.
[9] M. Varia,et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. , 1997, International journal of radiation oncology, biology, physics.
[10] G. Rosner,et al. Quantification of CCI-103F labeling heterogeneity in canine solid tumors. , 1997, International journal of radiation oncology, biology, physics.
[11] C. Koch,et al. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status. , 1997, Advances in experimental medicine and biology.
[12] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[13] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[14] C. Koch,et al. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. , 1996, The Journal of pharmacology and experimental therapeutics.
[15] C. Koch,et al. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. , 1996, Cancer research.
[16] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] C. Koch,et al. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity. , 1995, British Journal of Cancer.
[18] C. Koch,et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. , 1995, British Journal of Cancer.
[19] W. Curran,et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] K. Groebe,et al. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids , 1995, International journal of cancer.
[21] L. Harwell,et al. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. , 1993, Cancer research.
[22] P Vaupel,et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] T W Griffin,et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.
[24] D. Thrall,et al. Development of an ELISA for the detection of 2-nitroimidazole hypoxia markers bound to tumor tissue. , 1992, International journal of radiation oncology, biology, physics.
[25] G. Wilson,et al. Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. , 1991, British Journal of Cancer.
[26] D. Thrall,et al. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. , 1990, British Journal of Cancer.
[27] C. Coleman,et al. Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03. , 1990, International journal of radiation oncology, biology, physics.
[28] R E Durand,et al. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. , 1990, Radiation research.
[29] R. Gatenby,et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. , 1988, International journal of radiation oncology, biology, physics.
[30] C. Koch,et al. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. , 1987, Cancer research.
[31] C. J. Koch,et al. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. , 1987, British Journal of Cancer.
[32] J. Chapman,et al. The detection and measurement of hypoxic cells in solid tumors , 1984, Cancer.
[33] P. Olive,et al. Fluorescent nitroheterocycles for identifying hypoxic cells. , 1983, Cancer research.
[34] A J Dembo,et al. Definitive evidence for hypoxic cells influencing cure in cancer therapy. , 1978, The British journal of cancer. Supplement.
[35] J. Sirácky,et al. The effect of anemia on the radiotherapy results of the uterine cervix cancer. , 1975, Neoplasma.
[36] P. Kolstad. Oxygen Tension and Radiocurability in Cancer of the Cervix , 1964, Acta obstetricia et gynecologica Scandinavica.
[37] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.